What is Wellthy Therapeutics?
Wellthy Therapeutics is dedicated to revolutionizing diabetes care by developing a patient-centric digital solution. The company leverages advanced digital interventions and management tools to empower individuals with diabetes. With a stated focus on a world-class team, a global advisory board, and strong design capabilities, Wellthy Therapeutics aims to execute its vision effectively. The company's approach integrates technology with comprehensive patient support to improve health outcomes.
How much funding has Wellthy Therapeutics raised?
Wellthy Therapeutics has raised a total of $4M across 1 funding round:
Other Financing Round
$4M
Other Financing Round (2020): $4M with participation from Saama Capital
Key Investors in Wellthy Therapeutics
Saama Capital
Saama Capital is a venture capital firm focused on empowering entrepreneurs across diverse sectors. They invest in companies with ambitious visions and strong leadership, aiming to foster innovation and market disruption.
What's next for Wellthy Therapeutics?
The recent major strategic investment signals a pivotal growth phase for Wellthy Therapeutics. This capital infusion is expected to accelerate the company's product development, expand its market reach, and enhance its digital management platform. The strategic nature of this financing suggests potential collaborations or deeper integration with partners in the healthcare ecosystem, positioning Wellthy Therapeutics for significant scaling and impact in the diabetes digital health market.
See full Wellthy Therapeutics company page
